• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Nominations open for the Leonard Award celebrating 100 years of insulin

June 30, 2021 By Brian Buntz

Eli Lilly and CompanyEli Lilly (NYSE:LLY) is looking for nominations for its inaugural Leonard Award, which highlights advances in diabetes management. The company will select five winners and donate $100,00 to the non-profit Life for a Child, which provides medicines and supplies to children and youth with type 1 diabetes in developing countries. 

Lilly is launching the award program to commemorate the 100th anniversary of the discovery of insulin in 1921. Sir Frederick G. Banting, Charles H. Best and J.J.R. Macleod at the University of Toronto discovered the hormone in 1921. James B. Collip later purified it, giving rise to the first use of insulin to treat diabetes on January 11, 1922. The launch of commercial insulin occurred in 1923. 

Lilly is accepting nominations until August 31. Nominees must submit an overview of an original project, innovation or effort beyond therapy. The project should either support the diabetes community or address a need or challenge related to diabetes management.  

The company has enlisted the help of an external panel of judges who are experts in diabetes care to select winners.

The award program aims to recognize diverse champions dedicated to advancing diabetes management through innovative thinking and novel approaches in the following categories:

  • Teen/young adult
  • Advocate/advocacy professional
  • Endocrinologist/primary care physician
  • Diabetes educator/nurse
  • Researcher 

For each winner of the winners in those five categories, Lilly will donate $20,000 to Life for a Child.

The nomination form and more information about the award program are available on Lilly’s website. 

Filed Under: Diabetes, Featured Tagged With: Eli Lilly, insulin, Leonard Award, Life for a Child, type 1 diabetes

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

About Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS